A clinical study found that, during the perioperative period in laparoscopic radical procedures in patients with cervical cancer, the number of CD3-positive (+), CD4+, and NK cells, and the ratio of CD4+/CD8+ cells in the sevoflurane anesthesia group were significantly lower than those in the propofol anesthesia group, indicating that propofol may be beneficial in reducing perioperative immunosuppression, thus mitigating adverse prognoses in patients with cervical cancer (Liu et al., 2016). Here, CD4 is linked to cervical carcinoma.